Evommune’s EVO756 fails phase 2b trial in chronic urticaria

HomeFinanceEvommune’s EVO756 fails phase 2b trial in chronic urticaria

DAAZLabs - help businesses adopt artificial intelligence in a way that is legal, private, and genuinely useful — without the complexity that usually comes with it.

Home
services
AI Design
About Us
Audit
NewsSync
Global Market Prices
Contact

Contact Info

Email: [email protected]
Website: daazlabs.com
Opening hours: Monday – Friday, 9h – 18h

English

Portuguese